Real-world evidence of ocrelizumab-treated relapsing multiple sclerosis cohort shows changes in progression independent of relapse activity mirroring phase 3 trials

J. Ingwersen, L. Masanneck, M. Pawlitzki, S. Samadzadeh, M. Weise, O. Aktas, S. G. Meuth, P. Albrecht*

*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

12 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Real-world evidence of ocrelizumab-treated relapsing multiple sclerosis cohort shows changes in progression independent of relapse activity mirroring phase 3 trials'. Together they form a unique fingerprint.

Neuroscience